ClinicalTrialsFinder
CompletedPhase 4ACTRN12611000183987

Efficacy of continuous preperitoneal infusion of ropivacaine in laparoscopic colorectal surgery

Efficacy of postoperative continuous preperitoneal infusion of 0.5% ropivacaine at 4ml/hr after laparoscopic colorectal surgery compared to intravenous patient controlled postoperative analgesia

Sponsor

Samsung Medical Center

Enrollment

46 participants

Start Date

Jun 8, 2011

Study Type

Interventional

Conditions

This study investigates postoperative analgesic efficacy and recovery in patients receiving continuous preperitoneal ropivacaine infusion vs. intravenous patient controlled analgesia after laparoscopic colorectal surgery.

Summary

This controlled double blinded randomized clinical study intend to investigate postoperative analgesia and bowel recovery thus overall recovery efficacy of continuous preperitoenal infusion of 0.5% ropivacaine compared to intravenous opioid based patient controlled postoeprative analgesia. The main hypothesis of this study is that analgesic method using local anesthetic will provide equivalent or better analgesia with prompt bowel recovery.

Eligibility

Sex: Both males and femalesMin Age: 20 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether continuously infusing a pain-relief medication (ropivacaine) near the surgical site can improve pain management after laparoscopic bowel surgery. It is for adults aged 20-65 with moderate health conditions. People who currently take opioid pain medication, have bleeding disorders, neurological conditions, or are obese (BMI over 30) cannot participate.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intervention consists preperitoneal placement of catheter with multiple side-holes to continuously release 0.5%ropivacaine at 4ml/hr for postoperative 72hours. This placement will be conducted by an e

Intervention consists preperitoneal placement of catheter with multiple side-holes to continuously release 0.5%ropivacaine at 4ml/hr for postoperative 72hours. This placement will be conducted by an experienced attending surgeon. Intervention with 0.5% ropivacaine (local anesthetics) continuous infusion at 4ml/hr

Locations(1)

Korea, Republic Of

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000183987